The Academy of Managed Care Pharmacy (AMCP) is seeking input on the latest draft of its format for manufacturer-payer communications as it looks to align it with the Food and Drug Administration’s guidance, “Drug and Device Manufacturer Communications with Payors, Formulary Committees, and Similar Entities.”
AMCP’s format, “Format for Formulary Submissions Version 4.1: Guidance on Submissions of Post-approval and Pre-approval Clinical and Economic Information and Evidence,” will be open to public input until June 17. The final version is slated to be released in October during AMCP’s Nexus 2019 meeting.
Read more on the National Pharmaceutical Council’s website here.
To submit comments and read AMCP’s latest draft, click here.